secwatch / observer

8-K filed June 1, 2026, 9:06 AM ET ticker ONCY CIK 0001129928

other material confidence high sentiment positive materiality 0.45

Oncolytics reports positive initial preclinical data for pelareorep + RAS inhibitors; further studies planned

ONCOLYTICS BIOTECH INC

Initial data in solid tumor model shows greater anti-tumor activity with pelareorep+RAS inhibitor vs either alone.
Company planning additional studies in pancreatic ductal adenocarcinoma (PDAC) and colorectal cancer (CRC) models.
Evaluating combinations with KRAS G12C inhibitors, pan-RAS inhibitors, and next-generation RAS-targeted agents.
Full dataset expected to be presented in fall/winter 2026.
CEO states belief that pelareorep may serve as immune-priming backbone for next-generation targeted therapies.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001129928-26-000037
form_type: 8-K
ticker: ONCY
cik: 0001129928
company_name: ONCOLYTICS BIOTECH INC
filed_at: 2026-06-01T13:06:14+00:00
discovered_at: 2026-06-01T13:07:00.309068+00:00
generated_at: 2026-06-01T13:07:25.569744+00:00
sec_items: ["8.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001129928-26-000037
json_url: https://secwatch.observer/filing/0001129928-26-000037.json
markdown_url: https://secwatch.observer/filing/0001129928-26-000037.md
text_url: https://secwatch.observer/filing/0001129928-26-000037.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1129928/000112992826000037/0001129928-26-000037-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1129928/000112992826000037/oncy-20260601.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

BUKS

CEO Christopher Reedy discloses ongoing cancer treatment; remains in role

BUTLER NATIONAL CORP June 1, 2026, 12:41 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CPSH

CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share

CPS TECHNOLOGIES CORP/DE/ June 1, 2026, 9:35 AM ET other_material Items 1.01, 5.03, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CLIR

ClearSign Technologies prices 777,780-share public offering at $4.33/share for ~$3.37M gross proceeds

ClearSign Technologies Corp June 1, 2026, 8:30 AM ET other_material Items 1.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

RDAC

Shareholders approve SPAC extension to Oct 15, 2027; ~1.9M shares redeemed

Rising Dragon Acquisition Corp. June 1, 2026, 6:08 AM ET other_material Items 1.01, 5.03, 5.07, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

APUR

Aperture AC closes IPO of 10.2M units at $10/unit, raises $102M; trust funded with $102.255M

Aperture AC May 29, 2026, 4:15 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

ORRF

Orrstown redeems $31M sub notes due 2030; discloses third-party vendor cyber incident affecting customers

ORRSTOWN FINANCIAL SERVICES INC May 29, 2026, 4:05 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

OHAC

Oceanhawk Acquisition Corp closes SPAC IPO; raises $184M, trust funded with $184.92M

Oceanhawk Acquisition Corp. May 29, 2026, 4:00 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

TRLC

TriLinc Global Impact Fund portfolio assets ~$283M as of April 30, 2026

TriLinc Global Impact Fund LLC June 1, 2026, 12:43 PM ET other_material Items 8.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001129928-26-000037

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.